A survey of Asia-Pacific physicians highlights suboptimal patient compliance with post-MI aspirin prophylaxis and identifies a need for educational initiatives.
Physician-reported post-MI aspirin compliance appears suboptimal; cross-sectional data leaves open whether therapy modifications improve adherence.
Mortality from cardiovascular diseases, such as myocardial infarction (MI), is predicted to increase dramatically in Asia-Pacific countries. However, there are few studies that estimate utilization of prophylactics, such as low-dose aspirin, in these countries. To determine this, an online survey was sent to physicians in 18 countries worldwide, and this article reports the findings from the Asia-Pacific region (N = 4372 respondents). The overall mean number of MI patients per respondent was 246 in the Asia-Pacific countries, and 55% of physicians (overall) rated their patient as having total compliance with aspirin. The use of aspirin monotherapy or combination therapy, aspirin dosage, and physician contact were all found to have a significant impact on compliance (all P < 0.00001). Educational material on the role of aspirin was ranked as the most effective measure to improve compliance. In conclusion, this survey indicates that educational initiatives on secondary prevention are urgently needed in Asia-Pacific countries.
No takes yet. Share an insight, caveat, or question.
Zaninelli et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: